112 related articles for article (PubMed ID: 10443704)
1. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells.
Castro MR; Bergert ER; Beito TG; McIver B; Goellner JR; Morris JC
J Clin Endocrinol Metab; 1999 Aug; 84(8):2957-62. PubMed ID: 10443704
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
[TBL] [Abstract][Full Text] [Related]
3. Expression of the sodium iodide symporter in human kidney.
Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.
Jhiang SM; Cho JY; Ryu KY; DeYoung BR; Smanik PA; McGaughy VR; Fischer AH; Mazzaferri EL
Endocrinology; 1998 Oct; 139(10):4416-9. PubMed ID: 9751526
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
6. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands.
Spitzweg C; Joba W; Schriever K; Goellner JR; Morris JC; Heufelder AE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4178-84. PubMed ID: 10566669
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
[TBL] [Abstract][Full Text] [Related]
10. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
Pohlenz J; Duprez L; Weiss RE; Vassart G; Refetoff S; Costagliola S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2366-9. PubMed ID: 10902780
[TBL] [Abstract][Full Text] [Related]
11. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
12. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
13. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
14. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
[TBL] [Abstract][Full Text] [Related]
15. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
[TBL] [Abstract][Full Text] [Related]
16. Sodium iodide symporter (NIS) gene expression in human placenta.
Mitchell AM; Manley SW; Morris JC; Powell KA; Bergert ER; Mortimer RH
Placenta; 2001; 22(2-3):256-8. PubMed ID: 11170832
[TBL] [Abstract][Full Text] [Related]
17. The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species.
Selmi-Ruby S; Watrin C; Trouttet-Masson S; Bernier-Valentin F; Flachon V; Munari-Silem Y; Rousset B
Endocrinology; 2003 Mar; 144(3):1074-85. PubMed ID: 12586784
[TBL] [Abstract][Full Text] [Related]
18. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.
Smanik PA; Ryu KY; Theil KS; Mazzaferri EL; Jhiang SM
Endocrinology; 1997 Aug; 138(8):3555-8. PubMed ID: 9231811
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
[TBL] [Abstract][Full Text] [Related]
20. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
